- You need to enter an Access ID to request the Galleri test.
- For OMNI employees, your Access ID will be your Position ID, which can be found in ADP or on your electronic paystub.
- Eligible OMNI spouses will use the employee's Position ID.
- By entering an Access ID and pressing the button below, you will be exiting Galleri.com for a secure patient portal.
Introducing the Galleri multi-cancer early detection test
Galleri is a blood test that can detect 50+ cancer types and can be taken annually.1,2
The Galleri test is available by prescription only. The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.
Patient Story: Roger, Cancer Signal Detected with the Galleri test
Patient Story: Roger, Cancer Signal Detected with the Galleri test
The Galleri test is available by prescription only. The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.
Why is early detection important?
The Galleri test can increase your chance of finding a signal associated with cancer early, when used in addition to single cancer screenings.1 The Galleri test looks for a signal associated with active cancer and does not predict your future genetic risk for cancer.
Only 5 recommended cancer screening tests exist today2:
breast, colorectal, lung (for those at risk), cervical, and prostate
Who is eligible?
The Galleri test is available as a no cost benefit to eligible employees and covered spouses age 50 and older or ages 30-49 with risk factors.
Employees
- Age 50 and older
- Ages 30-49 with certain risk factors
- Personal history of cancer⁺
- Current smoker or history of smoking
- Obesity
- Diabetes
- Family history of cancer (first-degree relative)
- Hereditary genetic predisposition
- Occupational exposures (e.g. burn pits, asbestos)
- Environmental exposures (e.g. alcohol consumption, sun exposure)
- Medical conditions
- Autoimmune chronic inflammatory conditions (e.g., IBD, asthma)
- Nonautoimmune chronic inflammatory conditions (e.g., cirrhosis, chronic hepatitis B/C)
- Immunodeficiencies (e.g., primary or viral, such as HIV or HPV)
- Solid organ transplantation
Please note that the Galleri test is not available for people who are currently pregnant or undergoing cancer treatment.
Dependents / Spouses
- Covered on OMNI’s medical plan
- Age 50 and older
- Ages 30-49 with certain risk factors
- Personal history of cancer⁺
- Current smoker or history of smoking
- Obesity
- Diabetes
- Family history of cancer (first degree relative)
- Hereditary genetic predisposition
- Occupational exposures (e.g. burn pits, asbestos)
- Environmental exposures (e.g. alcohol consumption, sun exposure)
- Medical conditions
- Autoimmune chronic inflammatory conditions (e.g. IBD, asthma)
- Non-autoimmune chronic inflammatory conditions (e.g. cirrhosis, chronic hepatitis B/C)
- Immunodeficiencies (e.g. primary or viral, such as HIV or HPV)
- Solid organ transplantation
Please note that the Galleri test is not available for people who are currently pregnant or undergoing cancer treatment.
Note to dependents: Use the employee’s Access ID when requesting the test.
Limited data exists regarding the performance of Galleri in individuals <50 years of age.2,3,4
Screen for more in 4 simple steps
Request the test
It will take about 10 minutes to complete an online health questionnaire about your medical history. The Galleri test, by GRAIL, is available by prescription only. By requesting the test and completing the questionnaire, you’re requesting a prescription from Recuro Health, an independent telemedicine provider.
Receive a collection kit
If the Recuro Health telemedicine provider confirms your eligibility and prescribes the Galleri test, you will receive a notification via email and a collection kit in the mail. Visit Galleri.com/schedule to book your blood draw appointment at a GRAIL blood draw partner.
Provide your sample
Bring your test kit and Test Requisition Form (TRF) with you to the appointment. A trained technician will draw your blood sample and ship the kit to the GRAIL lab.
Receive your results
Recuro Health will contact you when your result is ready — about 2-3 weeks after your blood is received at the GRAIL lab.
What does the Galleri test result mean?
The Galleri test detected DNA fragments associated with cancer in your blood sample. About 1 out of every 100 test has a Cancer Signal Detected result.4
This result will also include a prediction of the issue type or organ associated with the cancer signal, called a Cancer Signal Origin (CSO). This provides direction to your doctor on the cancer’s origin and can help guide the next steps for diagnosis.2,5
In a clinical study, around 6 out of 10 people with a Cancer Signal Detected result were diagnosed with cancer after diagnostic testing.6*
*Based on the first ~25,000 participants with 1 year of follow-up.
The Galleri test does not detect a signal for all cancers, and false positive or false negative results can occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.
NEXT STEPS
A Cancer Signal Detected test result is not a cancer diagnosis and requires follow-up diagnostic testing. Such testing may include lab work or imagining ordered by your healthcare provider to confirm cancer.
The Galleri test did not detect DNA fragments associated with cancer in your blood sample.
Nearly 99% of people who use the Galleri test will screen negative.4
This result does not completely rule out the possibility of cancer. While the Galleri test is a powerful tool, it cannot detect a signal for all cancers and not all cancers can be detected in the blood. Some cancers shed little or no DNA into the bloodstream, making them unlikely to be detected through a blood test (e.g., brain, skin, and early-stage breast and prostate cancers).7 False positive and false negative results do occur. This result does not predict whether you will develop cancer in the future.
NEXT STEPS
Continue with any routine cancer screenings your healthcare provider recommends. Do not ignore cancer signs or symptoms if they occur, as this could lead to delayed diagnosis.
Cancer can be unpredictable. The Galleri test can be taken as a simple blood test. Adding the Galleri test to an annual routine can improve your chance of finding cancer early.8
Frequently Asked Questions for OMNI
OMNI benefit program will cover eligible employees and spouses 50+ years of age or ages 30-49 with additional risk factors and enrolled in the OMNI Medical Plan.
Use of the Galleri test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
The Galleri test should be used in addition to healthcare provider recommended screening tests. Galleri is available by prescription only.
To access the Galleri test as a covered benefit, you must request the test through this web page.
When you request the test, an independent telemedicine healthcare provider will review your request and order it if appropriate. The test is available by prescription only.
The Galleri test is a benefit fully covered by OMNI for eligible employees and/or spouses. Blood draw services, consultation, and return of results are included.
An at-home or in-lab blood draw is included in the price of the test if scheduled with one of our partner labs. Find a time and location convenient for you.
Your Access ID is your Position ID, which can be found in ADP or on your electronic paystub. If you have any difficulty locating your Position ID, please reach out to your HR representative.
Under the OMNI benefit program, eligible employees and spouses will be able to complete the Galleri test every 12 months.
To access the Galleri test as a covered benefit, you must request the test through this web page. An independent telemedicine provider will review your request and order the test, if appropriate.
The Galleri test is provided at no cost to eligible employees, dependents or spouses only when obtained through this authorized site: https://www.Galleri.com/omni
The blood draw associated with the Galleri test must occur on a date you are covered under this employee benefit.
Employees are responsible for the full cost of the test when obtained via any other means, such as a personal physician, or when the blood draw date of service occurs after the OMNI benefit coverage has ended.
Under the OMNI benefit program, eligible employees and spouses will be able to complete the Galleri test every 12 months.
Get support
For questions about the Galleri test, please contact GRAIL Customer Service:
By email: customerservice@grail.com
By telephone: (833) 694‑2553
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes
Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-77. DOI: https://doi.org/10.1016/j.annonc.2021.05.806.
The Galleri test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future. It should be used in addition to routine screening tests your healthcare provider recommends.